Better Living Through Data

This episode explores why Older Americans Month is really a call to action for healthier aging, focusing on function, prevention, and the importance of spotting early signs of decline. It also looks at how real-world data in long-term and post-acute care can help teams make more actionable decisions with greater clarity.To learn more about Study Buddy and gain free access visit: https://pointclickcare-lifesciences.lpages.co/studybuddyea/

This follow-up episode continues the Study Buddy conversation from a Pharma perspective, focusing on what it takes for a tool like this to move beyond a simple study helper and become part of real operational infrastructure. We dig into study startup friction, cross-functional handoffs, document control, training records, site alignment, and why adoption across sponsors, CROs, and sites matters more than a polished demo.Part 1 explored the broader Study Buddy idea; this episode picks up the Pharma thread and goes deeper on the operational realities that determine whether a product truly fits the workflow. Listen to last week's episode (Season 2 - Episode 3 - Part 1) from our main menu.To learn more about Study Buddy and register for free access visit https://pointclickcare-lifesciences.lpages.co/studybuddyea/

Pharma teams don’t need more hype—they need a faster way to test whether a research question is feasible before committing time and budget. This episode explores how AI plus proprietary long-term and post-acute care data can surface earlier signal, reduce wasted detours, and help teams move with more confidence.To learn more about Study Buddy and register for free access visit https://pointclickcare-lifesciences.lpages.co/studybuddyea/

Andie Cartwright and Anthony Pero unpack the hidden bottleneck in long-term care research: all the time spent on feasibility checks, cohort building, and variable clarification before a study even begins. They also explore how Study Buddy can turn natural-language questions into structured, grant-ready outputs fast—helping researchers move from idea to critique in minutes, not months.Get free access to Study Buddy here: https://pointclickcare-lifesciences.lpages.co/studybuddyea/

In this Season 2 premiere, Andie Cartwright and Anthony Pero introduce Study Buddy, a new AI-powered natural language research tool designed to make long‑term care data usable, visible, and actionable. The episode explores how Study Buddy takes granular, longitudinal EHR data—captured daily across millions of older adults—and shortens the evidence cycle from months to minutes, supporting early‑stage study feasibility, and surfaces insights that improve research, care standards, and equity in aging populations.Learn more and gain access to Study Buddy for free: https://pointclickcare-lifesciences.lpages.co/studybuddyea/

In this episode, Andie and Anthony break down PointClickCare Life Sciences’ Commercial Dataset and how it helps teams understand the long-term care market, identify therapy opportunities, and measure commercial performance with recent, real-world data.They explore what makes the dataset unique, how market and orders views support different commercial questions, and why one-week data latency matters for teams working across long-term and post-acute care.

In this episode, Andie Cartwright and Anthony Pero unpack a new real-world EHR study on depression pharmacotherapy in long-term care. They explore how often residents with depression receive treatment, which medication classes are most common, and what the data reveal about disparities tied to race, comorbidities, and facility context.The conversation also looks at what these findings mean for screening, equitable prescribing, and strengthening depression care in socially vulnerable settings.

In recognition of National Kidney Month, Andie Cartwright and Anthony Pero explore chronic kidney disease through two critical lenses: the human impact on aging and vulnerable populations, and the role of real-world data in improving earlier identification, care planning, and outcomes.The episode examines how CKD often progresses silently, why older adults and historically underserved communities face disproportionate risk, and how better visibility across care settings can support more timely intervention. Drawing on current public-health context and the CKD brochure referenced for this episode, the conversation also highlights how datasets and longitudinal insights can help researchers, providers, and life sciences teams better understand disease burden and opportunities for action.National Kidney Month context and the urgency of CKD awarenessKey prevalence, awareness, and disparity trends in chronic kidney diseaseHow real-world data can inform research, risk stratification, and care decisions

Andie and Anthony explore the evolving use of medications in dementia care within long-term facilities, uncovering who benefits from treatment through a massive EHR study. The episode highlights demographic disparities, clinical challenges, and how real-world data can shape future policies to improve quality of life for those with ADRD.

In this episode, Andie and Anthony explore the surprising gaps in diabetes treatment among long-term care residents, revealing racial and regional disparities impacting medication access. Discover how real-world data is driving change to improve outcomes for vulnerable seniors.

Andie and Anthony explore the high rates of depression in long-term care and the disparities in treatment access revealed by real-world data. The episode highlights the urgent need for personalized approaches and trust-building to improve care for vulnerable populations.

Andie and Anthony explore the surprising under-treatment of hyperlipidemia in long-term care residents and the social disparities that influence care. Discover how data-driven insights and clinical leadership can improve guideline adherence and enhance cardiovascular outcomes for vulnerable populations.

This episode explores how COVID-19 changed hypertension management in nursing homes, especially among residents with dementia. Hear insights on deprescribing challenges, balancing medication risks, and innovative protocols to improve quality of life in vulnerable populations.

Explore how treatment patterns vary among long-term care residents with dementia, uncovering disparities influenced by demographics and clinical factors. This episode highlights challenges like polypharmacy and the urgent need for new therapies, drawing on real-world insights to improve quality of life for vulnerable populations.

Explore groundbreaking research linking the herpes zoster vaccine to reduced dementia risk in nursing home residents. Dive into how advanced data methods validate these findings and discuss the critical need to improve vaccine uptake among vulnerable populations for better health outcomes.

Join Andie and Anthony as they explore groundbreaking research using PointClickCare’s Life Sciences dataset to uncover medication trends and disparities in senior populations. Discover how data-driven insights are shaping interventions that improve outcomes and foster collaboration across healthcare providers and payers.

Explore the milestone of vaccinating over 6 million residents against flu and its impact on vulnerable populations. Discover how data and collaboration drive effective vaccination campaigns and improve health outcomes in long-term care settings.

Explore the systemic barriers and disparities in medication access for older adults in long-term care facilities. Join hosts Andie Cartwright and Anthony Pero as they delve into PCC Life Sciences' research findings and discuss ways to improve treatment rates and guidelines.

Explore how PointClickCare Life Sciences is transforming care for aging populations with comprehensive data. Discover the impact of granular insights on drug development, clinical trials, and patient outcomes.

Join host Andie Cartwright as she explores how comprehensive datasets from PointClickCare Life Sciences are revolutionizing care for aging and vulnerable populations. Andie will discuss the data's role in enhancing patient outcomes and supporting healthcare advancements.